Sartorius Stedim Biotech S.A. (EPA: DIM)
France
· Delayed Price · Currency is EUR 185.60
+2.30 (1.25%)
Nov 12, 2024, 5:35 PM CET
Sartorius Stedim Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 160.6 | 309.7 | 876.1 | 414.4 | 335.93 | 234.5 | Upgrade
|
| Depreciation & Amortization | 271.7 | 214 | 162.3 | 126.4 | 86.69 | 64.31 | Upgrade
|
| Other Amortization | 23.6 | 23.6 | 19.4 | 15.2 | 15 | 9.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.13 | - | Upgrade
|
| Other Operating Activities | 134.6 | 8.4 | -94.2 | 291.6 | 22.73 | 32.45 | Upgrade
|
| Change in Accounts Receivable | 59.9 | 162.1 | -65.8 | -87.3 | -73.89 | 3.84 | Upgrade
|
| Change in Inventory | 231 | 131.2 | -217.9 | -275.4 | -116.62 | -65.96 | Upgrade
|
| Change in Other Net Operating Assets | -15.1 | -102.6 | -67.6 | 217 | 146.91 | 31.94 | Upgrade
|
| Operating Cash Flow | 866.3 | 746.4 | 612.3 | 701.9 | 416.88 | 310.13 | Upgrade
|
| Operating Cash Flow Growth | 38.54% | 21.90% | -12.77% | 68.37% | 34.42% | 36.45% | Upgrade
|
| Capital Expenditures | -362.6 | -473.6 | -430.6 | -324 | -159.19 | -135.97 | Upgrade
|
| Cash Acquisitions | - | -2,241 | -515.6 | -141.7 | -470.62 | -48.4 | Upgrade
|
| Other Investing Activities | -8.2 | -8.2 | -11.3 | 0.5 | 8.69 | -0 | Upgrade
|
| Investing Cash Flow | -365 | -2,723 | -957.5 | -465.2 | -621.12 | -184.37 | Upgrade
|
| Long-Term Debt Issued | - | 2,649 | 566.8 | 74.2 | 334.79 | 0.65 | Upgrade
|
| Long-Term Debt Repaid | - | -326.4 | -174.4 | -79.7 | -35.32 | -60.49 | Upgrade
|
| Net Debt Issued (Repaid) | -969 | 2,323 | 392.4 | -5.5 | 299.47 | -59.84 | Upgrade
|
| Issuance of Common Stock | 1,193 | 1.3 | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | -2 | - | -3.2 | - | - | - | Upgrade
|
| Common Dividends Paid | -67.1 | -132.7 | -116.1 | -62.7 | -31.34 | -52.54 | Upgrade
|
| Other Financing Activities | -272.2 | -205.3 | -52.4 | -9.5 | -34.06 | -9.78 | Upgrade
|
| Financing Cash Flow | -117.6 | 1,986 | 220.7 | -77.7 | 234.07 | -122.16 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.6 | -0.3 | 8 | 4.8 | 1.77 | 0.59 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | 383.1 | 9.5 | -116.5 | 163.8 | 31.6 | 4.19 | Upgrade
|
| Free Cash Flow | 503.7 | 272.8 | 181.7 | 377.9 | 257.69 | 174.16 | Upgrade
|
| Free Cash Flow Growth | 347.34% | 50.14% | -51.92% | 46.65% | 47.96% | 243.17% | Upgrade
|
| Free Cash Flow Margin | 18.41% | 9.83% | 5.20% | 13.09% | 13.49% | 12.09% | Upgrade
|
| Free Cash Flow Per Share | 5.28 | 2.96 | 1.97 | 4.10 | 2.80 | 1.89 | Upgrade
|
| Cash Interest Paid | 271.2 | 116.7 | 10.3 | 8.3 | 8.06 | 10.53 | Upgrade
|
| Cash Income Tax Paid | 103.8 | 135.8 | 221.2 | 166.6 | 113.98 | 65.33 | Upgrade
|
| Levered Free Cash Flow | 221.75 | 81.41 | 93.93 | 425.14 | 219.13 | 149.02 | Upgrade
|
| Unlevered Free Cash Flow | 356.81 | 153.54 | 105.3 | 431.51 | 223.2 | 151.44 | Upgrade
|
| Change in Net Working Capital | -174.8 | -96.6 | 304.8 | -37.89 | 34.63 | 4.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.